Clinical Trial

DBM-1152A Inhalation Solution in Chinese Healthy Subjects

Name: DBM-1152A Inhalation Solution in Chinese Healthy Subjects — clinical trial record (NCT07447141)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase Ia, single-center, randomized, double-blind, placebo-controlled, single ascending dose (SAD) study. The primary purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of DBM-1152A Inhalation Solution in healthy Chinese adult subjects.

Trial Details

NCT Number	NCT07447141
Lead Sponsor	Joincare Pharmaceutical Group Industry Co., Ltd Collaborators: Livzon Pharmaceutical Group Inc.
Conditions	Health, Health Adult Subjects
Enrollment	44 participants
Start Date	2023-12-24
Primary Completion	2024-04-08 (estimated)
Study Completion	2024-04-08 (estimated)
Updated on ClinicalTrials.gov	2026-03-03